• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

The role of ferroptosis in hepatocellular carcinoma

Research Project

Project/Area Number 19K09198
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Review Section Basic Section 55020:Digestive surgery-related
Research InstitutionKyushu University

Principal Investigator

Shinji ITOH  九州大学, 大学病院, 講師 (90382423)

Co-Investigator(Kenkyū-buntansha) 副島 雄二  信州大学, 学術研究院医学系, 教授 (30325526)
吉住 朋晴  九州大学, 医学研究院, 准教授 (80363373)
原田 昇  九州大学, 大学病院, 講師 (80419580)
池上 徹  九州大学, 大学病院, 講師 (80432938)
Project Period (FY) 2019-04-01 – 2022-03-31
Project Status Completed (Fiscal Year 2021)
Budget Amount *help
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2021: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2020: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Fiscal Year 2019: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Keywords肝細胞癌 / 肝内胆管癌 / フェロトーシス / 腫瘍免疫 / がん代謝 / PD-L1 / Nrf2 / VETC / ストレス応答 / 代謝リプログラミング / 原発性肝癌 / 腫瘍内類洞様血管構築 / 酸化ストレス / 癌微小環境
Outline of Research at the Start

臨床で遭遇する肝癌における脈管浸潤による外科的切除後の高頻度の再発、焼灼療法や血管塞栓術後の局所再発、薬剤抵抗性の病態機序を解明する研究である。本研究の特徴として、肝癌においてフェロトーシス回避の機序および微小環境と代謝リプログラミングとの関連を明らかにすることである。肝細胞癌の悪性化・進展に関する分子機構の解明に寄与し、この機序の解明により革新的治療の開発に繋がると予想される。

Outline of Final Research Achievements

We focused on the tumor microenvironment in primary liver cancer (hepatocellular carcinoma and intrahepatic cholangiocarcinoma), and investigate the relationship with clinical data. We found novel findings on the immune response and vascular formation in the tumor microenvironment. We also elucidated inflammatory markers and preoperative imaging findings that predict the tumor microenvironment. We also identified proteins that regulate PD-L1 expression in hepatocellular carcinoma and elucidated their signaling pathways and clinical significance.
We demonstrated for the first time that administration of novel molecularly targeted agent (lenvatinib) induces ferroptosis in hepatocellular carcinoma, elucidated the significance of the FGFR4 signaling pathway, and demonstrated that the Nrf2 protein was involved in drug sensitivity.

Academic Significance and Societal Importance of the Research Achievements

難治性癌の一つである原発性肝癌(肝細胞癌、肝内胆管癌)において、癌微小環境の新知見を同定し、炎症マーカーや画像所見との関係を明らかにした。原発性肝癌での微小環境を反映した新たな新規バイオマーカー候補を明らかにした。
肝細胞癌における分子標的薬におけるフェロトーシス誘導、およびその感受性の機序を明らかにした。フェロトーシスの研究により薬物療法の治療効果の向上に寄与する。

Report

(4 results)
  • 2021 Annual Research Report   Final Research Report ( PDF )
  • 2020 Research-status Report
  • 2019 Research-status Report
  • Research Products

    (36 results)

All 2022 2021 2020 2019

All Journal Article (21 results) (of which Int'l Joint Research: 1 results,  Peer Reviewed: 21 results,  Open Access: 9 results) Presentation (15 results) (of which Invited: 1 results)

  • [Journal Article] Myeloid-derived suppressor cell infiltration is associated with a poor prognosis in patients with hepatocellular carcinoma2022

    • Author(s)
      Tomiyama Takahiro、Itoh Shinji、Iseda Norifumi、Toshida Katuya、Morinaga Akinari、Yugawa Kyohei、Fujimoto Yukiko、Tomino Takahiro、Kurihara Takeshi、Nagao Yoshihiro、Morita Kazutoyo、Harada Noboru、Kohashi Kenichi、Oda Yoshinao、Mori Masaki、Yoshizumi Tomoharu
    • Journal Title

      Oncology Letters

      Volume: 23 Issue: 3 Pages: 93-93

    • DOI

      10.3892/ol.2022.13213

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Prognostic impact of tumor microvessels in intrahepatic cholangiocarcinoma: association with tumor-infiltrating lymphocytes2021

    • Author(s)
      Yugawa Kyohei、Itoh Shinji、Yoshizumi Tomoharu、Iseda Norifumi、Tomiyama Takahiro、Toshima Takeo、Harada Noboru、Kohashi Kenichi、Oda Yoshinao、Mori Masaki
    • Journal Title

      Modern Pathology

      Volume: 34 Issue: 4 Pages: 798-807

    • DOI

      10.1038/s41379-020-00702-9

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Prognostic significance of systemic inflammation score in patients who undergo hepatic resection for hepatocellular carcinoma.2021

    • Author(s)
      Inokuchi S, Itoh S, Yoshizumi T, Morinaga A, Toshima T, Takeishi K, Nagao Y, Harada N, Ikegami T, Shimokawa M, Mori M.
    • Journal Title

      Langenbecks Arch Surg.

      Volume: Epub Issue: 3 Pages: 773-779

    • DOI

      10.1007/s00423-021-02103-1

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed
  • [Journal Article] A no-ligation technique to prevent intraoperative hepatic artery dissection in living-donor liver transplantation.2021

    • Author(s)
      Itoh S, Yoshizumi T, Harada N, Toshima T,Nagao Y, Kurihara T, Wang H, Shimagaki T, Ikegami T, Mori M.
    • Journal Title

      Surg Today.

      Volume: Epub Issue: 11 Pages: 1877-1880

    • DOI

      10.1007/s00595-021-02276-8

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed
  • [Journal Article] ARID1A Deficiency Is Associated With High Programmed Death Ligand 1 Expression in Hepatocellular Carcinoma2021

    • Author(s)
      Iseda Norifumi、Itoh Shinji、Yoshizumi Tomoharu、Yugawa Kyohei、Morinaga Akinari、Tomiyama Takahiro、Toshima Takeo、Kohashi Kenichi、Oda Yoshinao、Mori Masaki
    • Journal Title

      Hepatology Communications

      Volume: 5 Issue: 4 Pages: 675-688

    • DOI

      10.1002/hep4.1659

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Lymphocyte-C-reactive protein ratio as a prognostic marker associated with the tumor immune microenvironment in intrahepatic cholangiocarcinoma2021

    • Author(s)
      Yugawa Kyohei、Itoh Shinji、Yoshizumi Tomoharu、Morinaga Akinari、Iseda Norifumi、Toshima Takeo、Harada Noboru、Kohashi Kenichi、Oda Yoshinao、Mori Masaki
    • Journal Title

      International Journal of Clinical Oncology

      Volume: 26 Issue: 10 Pages: 1901-1910

    • DOI

      10.1007/s10147-021-01962-4

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Lymphocyte-to-C-reactive protein ratio as a prognostic factor for hepatocellular carcinoma2021

    • Author(s)
      Iseda Norifumi、Itoh Shinji、Yoshizumi Tomoharu、Tomiyama Takahiro、Morinaga Akinari、Shimagaki Tomonari、Wang Huanlin、Kurihara Takeshi、Toshima Takeo、Nagao Yoshihiro、Harada Noboru、Oda Yoshinao、Mori Masaki
    • Journal Title

      International Journal of Clinical Oncology

      Volume: 26 Issue: 10 Pages: 1890-1900

    • DOI

      10.1007/s10147-021-01985-x

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Impact and risk factors for skeletal muscle mass loss after hepatic resection in patients with hepatocellular carcinoma2021

    • Author(s)
      Itoh Shinji、Yoshizumi Tomoharu、Tomiyama Takahiro、Iseda Norifumi、Morinaga Akinari、Shimagaki Tomonari、Wang Huanlin、Kurihara Takeshi、Nagao Yoshihiro、Toshima Takeo、Harada Noboru、Nishie Akihiro、Ishigami Kousei、Mori Masaki
    • Journal Title

      JGH Open

      Volume: 5 Issue: 7 Pages: 785-792

    • DOI

      10.1002/jgh3.12588

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Impact of Metabolic Activity in Hepatocellular Carcinoma: Association With Immune Status and Vascular Formation2021

    • Author(s)
      Itoh Shinji、Yoshizumi Tomoharu、Kitamura Yoshiyuki、Yugawa Kyohei、Iseda Norifumi、Shimagaki Tomonari、Nagao Yoshihiro、Toshima Takeo、Harada Noboru、Kohashi Kenichi、Baba Shingo、Ishigami Kousei、Oda Yoshinao、Mori Masaki
    • Journal Title

      Hepatology Communications

      Volume: 5 Issue: 7 Pages: 1278-1289

    • DOI

      10.1002/hep4.1715

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Retrospective evaluation of the effect of Ninjin’yoeito in hepatocellular carcinoma patients treated with lenvatinib2021

    • Author(s)
      Toshida Katsuya、Itoh Shinji、Yoshizumi Tomoharu、Shimagaki Tomonari、Wang Huanlin、Kurihara Takeshi、Toshima Takeo、Nagao Yoshihiro、Harada Noboru、Hata Kojiro、Makihara Yoko、Watanabe Hiroyuki、Mori Masaki
    • Journal Title

      Surgery Today

      Volume: 52 Issue: 3 Pages: 441-448

    • DOI

      10.1007/s00595-021-02358-7

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Prognostic significance of preoperative PNI and CA19-9 for pancreatic ductal adenocarcinoma: A multi-institutional retrospective study2021

    • Author(s)
      Itoh Shinji、Tsujita Eiji、Fukuzawa Kengo、Sugimachi Keishi、Iguchi Tomohiri、Ninomiya Mizuki、Maeda Takashi、Kajiyama Kiyashi、Adachi Eisuke、Uchiyama Hideaki、Utsunomiya Tohru、Ikeda Yasuharu、Maekawa Soichirou、Toshima Takeo、Harada Noboru、Yoshizumi Tomoharu、Mori Masaki
    • Journal Title

      Pancreatology

      Volume: 21 Issue: 7 Pages: 1356-1363

    • DOI

      10.1016/j.pan.2021.08.003

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Impact of Nuclear Factor Erythroid 2?Related Factor 2 in Hepatocellular Carcinoma: Cancer Metabolism and Immune Status2021

    • Author(s)
      Iseda Norifumi、Itoh Shinji、Yoshizumi Tomoharu、Tomiyama Takahiro、Morinaga Akinari、Yugawa Kyohei、Shimokawa Masahiro、Shimagaki Tomonari、Wang Huanlin、Kurihara Takeshi、Kitamura Yoshiyuki、Nagao Yoshihiro、Toshima Takeo、Harada Noboru、Kohashi Kenichi、Baba Shingo、Ishigami Kousei、Oda Yoshinao、Mori Masaki
    • Journal Title

      Hepatology Communications

      Volume: 6 Issue: 4 Pages: 665-678

    • DOI

      10.1002/hep4.1838

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Immune microenvironment in primary and metastatic liver cancers2021

    • Author(s)
      Itoh Shinji、Yugawa Kyohei、Yoshizumi Tomoharu、Oda Yoshinao、Mori Masaki
    • Journal Title

      Hepatology Research

      Volume: 51 Issue: 1 Pages: 3-4

    • DOI

      10.1111/hepr.13607

    • Related Report
      2020 Research-status Report
    • Peer Reviewed
  • [Journal Article] CMTM6 Stabilizes PD‐L1 Expression and Is a New Prognostic Impact Factor in Hepatocellular Carcinoma2021

    • Author(s)
      Yugawa Kyohei、Itoh Shinji、Yoshizumi Tomoharu、Iseda Norifumi、Tomiyama Takahiro、Morinaga Akinari、Toshima Takeo、Harada Noboru、Kohashi Kenichi、Oda Yoshinao、Mori Masaki
    • Journal Title

      Hepatology Communications

      Volume: 5 Issue: 2 Pages: 334-348

    • DOI

      10.1002/hep4.1643

    • Related Report
      2020 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Obesity is a risk factor for intrahepatic cholangiocarcinoma progression associated with alterations of metabolic activity and immune status2021

    • Author(s)
      Yugawa Kyohei、Itoh Shinji、Iseda Norifumi、Kurihara Takeshi、Kitamura Yoshiyuki、Toshima Takeo、Harada Noboru、Kohashi Kenichi、Baba Shingo、Ishigami Kousei、Oda Yoshinao、Yoshizumi Tomoharu、Mori Masaki
    • Journal Title

      Scientific Reports

      Volume: 11 Issue: 1 Pages: 5845-5845

    • DOI

      10.1038/s41598-021-85186-6

    • Related Report
      2020 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Modulation of Nqo1 activity intercepts anoikis resistance and reduces metastatic potential of hepatocellular carcinoma2020

    • Author(s)
      Shimokawa Masahiro、Yoshizumi Tomoharu、Itoh Shinji、Iseda Norifumi、Sakata Kazuhito、Yugawa Kyohei、Toshima Takeo、Harada Noboru、Ikegami Toru、Mori Masaki
    • Journal Title

      Cancer Science

      Volume: 111 Issue: 4 Pages: 1228-1240

    • DOI

      10.1111/cas.14320

    • Related Report
      2020 Research-status Report 2019 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Is sarcopenic obesity superior to sarcopenia as a predicting indicator in patients with hepatocellular carcinoma following hepatic resection?2020

    • Author(s)
      Itoh Shinji、Yoshizumi Tomoharu、Mori Masaki
    • Journal Title

      Hepatobiliary Surgery and Nutrition

      Volume: 9 Issue: 2 Pages: 202-204

    • DOI

      10.21037/hbsn.2019.09.14

    • Related Report
      2020 Research-status Report 2019 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Prognostic impact of 8‐hydroxy‐deoxyguanosine and its repair enzyme 8‐hydroxy‐deoxyguanosine DNA glycosylase in hepatocellular carcinoma2020

    • Author(s)
      Yugawa Kyohei、Itoh Shinji、Yoshizumi Tomoharu、Yoshiya Shohei、Takeishi Kazuki、Toshima Takeo、Harada Noboru、Ikegami Toru、Kohashi Kenichi、Oda Yoshinao、Mori Masaki
    • Journal Title

      Pathology International

      Volume: 70 Issue: 8 Pages: 533-541

    • DOI

      10.1111/pin.12952

    • Related Report
      2020 Research-status Report
    • Peer Reviewed
  • [Journal Article] Mitochondrial expression of the DNA repair enzyme OGG1 improves the prognosis of pancreatic ductal adenocarcinoma2020

    • Author(s)
      Inokuchi Shoichi、Itoh Shinji、Yoshizumi Tomoharu、Yugawa Kyohei、Yoshiya Shohei、Toshima Takeo、Takeishi Kazuki、Iguchi Tomohiro、Sanefuji Kensaku、Harada Noboru、Sugimachi Keishi、Ikegami Toru、Kohashi Kenichi、Taguchi Kenichi、Yonemasu Hirotoshi、Fukuzawa Kengo、Oda Yoshinao、Mori Masaki
    • Journal Title

      Pancreatology

      Volume: 20 Issue: 6 Pages: 1175-1182

    • DOI

      10.1016/j.pan.2020.07.011

    • Related Report
      2020 Research-status Report
    • Peer Reviewed
  • [Journal Article] C-reactive protein : albumin ratio in patients with resectable intrahepatic cholangiocarcinoma2020

    • Author(s)
      Matsumoto T、Itoh S、Yoshizumi T、Kurihara T、Yoshiya S、Mano Y、Takeishi K、Harada N、Ikegami T、Soejima Y、Baba H、Mori M
    • Journal Title

      BJS Open

      Volume: 4 Issue: 6 Pages: 1146-1152

    • DOI

      10.1002/bjs5.50348

    • Related Report
      2020 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Impact of Immune Response on Outcomes in Hepatocellular Carcinoma: Association with Vascular Formation2020

    • Author(s)
      Itoh Shinji、Yoshizumi Tomoharu、Yugawa Kyohei、Imai Daisuke、Yoshiya Shohei、Takeishi Kazuki、Toshima Takeo、Harada Noboru、Ikegami Toru、Soejima Yuji、Kohashi Kenichi、Oda Yoshinao、Mori Masaki
    • Journal Title

      Hepatology

      Volume: - Issue: 6 Pages: 1987-1999

    • DOI

      10.1002/hep.31206

    • Related Report
      2020 Research-status Report 2019 Research-status Report
    • Peer Reviewed / Int'l Joint Research
  • [Presentation] 肝細胞癌に対するストレス応答蛋白Nrf2と腫瘍免疫、がん代謝との関連2021

    • Author(s)
      伊藤心二、吉住朋晴、森 正樹
    • Organizer
      第107回日本消化器病学会総会
    • Related Report
      2021 Annual Research Report
  • [Presentation] 肝細胞癌に対するフェロトーシスと微小環境との関連2021

    • Author(s)
      伊藤心二、吉住朋晴、森永哲成、伊勢田憲史、冨山貴央、島垣智成、王 歓林、栗原 健、長尾吉泰、戸島剛男、原田 昇、森 正樹
    • Organizer
      第74回日本酸化ストレス学会学術集会
    • Related Report
      2021 Annual Research Report
  • [Presentation] 肝細胞癌集学的治療における層別化治療にむけた展開2021

    • Author(s)
      伊藤心二、吉住朋晴、森 正樹
    • Organizer
      第57回日本肝臓学会総会
    • Related Report
      2021 Annual Research Report
  • [Presentation] 肝細胞癌に対する腫瘍免疫に着目した個別化治療への展開2021

    • Author(s)
      伊藤心二、吉住朋晴、伊勢田憲史、島垣智成、王 歓林、栗原 健、長尾吉泰、戸島剛男、原田 昇、森 正樹
    • Organizer
      第76回日本消化器外科学会総会
    • Related Report
      2021 Annual Research Report
  • [Presentation] 肝細胞癌におけるレンバチニブ投与におけるフェロトーシスの役割2021

    • Author(s)
      伊藤心二、吉住朋晴、伊勢田憲史、原田 昇、森 正樹
    • Organizer
      第80回日本癌学会学術総会
    • Related Report
      2021 Annual Research Report
  • [Presentation] 原発性肝癌における癌代謝を反映するPET-CTと腫瘍免疫との関係2021

    • Author(s)
      伊藤心二、吉住朋晴、森 正樹
    • Organizer
      第29回日本消化器関連学会週間(JDDW2021)
    • Related Report
      2021 Annual Research Report
  • [Presentation] 肝細胞癌における腫瘍免疫の意義と腫瘍内血管構築との関係2020

    • Author(s)
      伊藤心二、吉住朋晴、森 正樹
    • Organizer
      第56回日本肝臓学会学術集会
    • Related Report
      2020 Research-status Report
  • [Presentation] 肝細胞癌おける8-OHdGとDNA修復酵素OGG1発現の意義2020

    • Author(s)
      伊藤心二、湯川恭平、吉住朋晴、長尾吉泰、武石一樹、戸島剛男、原田 昇、池上 徹、孝橋賢一、小田義直、森 正樹
    • Organizer
      第72回日本酸化ストレス学会学術集会
    • Related Report
      2020 Research-status Report
  • [Presentation] 肝細胞癌における免疫回避調節因子CMTM6の意義2020

    • Author(s)
      伊藤心二、吉住朋晴、森 正樹
    • Organizer
      JDDW2020 Kobe(第18回日本消化器外科学会大会)
    • Related Report
      2020 Research-status Report
  • [Presentation] 原発性肝癌における腫瘍免疫と癌代謝との関係2020

    • Author(s)
      伊藤心二、吉住朋晴、湯川恭平、伊勢田憲史、冨山貴央、森永哲成、島垣智成、王 歓林、栗原 健、長尾吉泰、戸島剛男、原田 昇、森 正樹
    • Organizer
      第31回日本消化器癌発生学会
    • Related Report
      2020 Research-status Report
  • [Presentation] 肝胆膵悪性腫瘍における宿主および腫瘍免疫の意義とストレス応答の役割2020

    • Author(s)
      伊藤心二
    • Organizer
      第31回日本消化器癌発生学会
    • Related Report
      2020 Research-status Report
    • Invited
  • [Presentation] Association of tumor-infiltrating CD8-T cells with programmed cell death-ligand 1 expression in hepatocellular carcinoma2019

    • Author(s)
      Itoh S, Yoshizumi T, Mori M
    • Organizer
      第78回日本癌学会学術総会
    • Related Report
      2019 Research-status Report
  • [Presentation] The Inflammatory Biomarkers in Hepatocellular Carcinoma Following Hepatic Resection: Prognostic Significance and Association with Programmed Death Ligand 1 Expression2019

    • Author(s)
      Itoh S, Yoshizumi T, Yugawa K, Kurihara T, Yoshiya S, Mano Y, Takeishi K, Harada N, Ikegami T, Soejima Y, Mori M
    • Organizer
      JDDW2019 Kobe
    • Related Report
      2019 Research-status Report
  • [Presentation] 肝細胞癌に対する腫瘍免疫と腫瘍内血管構築との関係2019

    • Author(s)
      伊藤心二、湯川恭平、伊勢田憲史、冨山貴央、森永哲成、小斉侑希子、井口詔一、吉屋匠平、武石一樹、戸島剛男、原田 昇、池上 徹、吉住朋晴、森 正樹
    • Organizer
      第30回日本消化器癌発生学会
    • Related Report
      2019 Research-status Report
  • [Presentation] 肝細胞癌の微小環境における腫瘍免疫と腫瘍内血管構築との関係2019

    • Author(s)
      第32回日本バイオセラピィ学会学術集会総会
    • Organizer
      伊藤心二、森 正樹
    • Related Report
      2019 Research-status Report

URL: 

Published: 2019-04-18   Modified: 2023-01-30  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi